Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

BACKGROUND: In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mil Med Res
Autores principales: Zhao, Xin, Yang, Xiao-Xu, Ji, Su-Zhen, Wang, Xiao-Zeng, Wang, Li, Gu, Chong-Huai, Ren, Li-Li, Han, Ya-Ling
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847352/
https://ncbi.nlm.nih.gov/pubmed/27123313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40779-016-0081-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares